As shown in Table 6, FGFR3 mutations may potentially affect bladder tumor recurrence in UTUC (OR, 11.00; 95% CI, 0.96–125.77; p = 0.054); however, the result was not statistically significant. This evidence concerns the gene FGFR3 and urinary bladder neoplasm.